Speculation that Mayne has a 2B offer to be bought out. Nothing confirmed by company. I wonder how this will affect SUPG on EU nipent sale. Also Mayne still may owe SUPG 20M on milestones of Nipent. Link I provided in earlier post updates frequently...so keep checking it for any update on Mayne.
Shares of Australia's Mayne Pharma are on the rise following hot rumors that it's about to become the subject of a takeover bid. Two generic drug outfits, Hospira and Teva, have been suggested as possible bidders. But other analysts are speculating that the rumors are being triggered by a possible bid by Mayne for another company. Spun out last year from the Mayne Group, Mayne Pharma has been posting losses while boasting of its new drug candidates.
- found in "The Australian"
PLUS: One report suggests that $1.5 billion is being offered for Mayne.